Volume 78, Issue 11, Pages (December 2010)

Slides:



Advertisements
Similar presentations
Kamyar Kalantar-Zadeh  Kidney International 
Advertisements

Steven Fishbane, Jeffrey S. Berns, M.D.  Kidney International 
Volume 63, Issue 3, Pages (March 2003)
Volume 65, Issue 6, Pages (June 2004)
Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants  C.A. Solid,
Anemia management in chronic kidney disease
Mitchell H. Rosner, W. Kline Bolton  Kidney International 
Association of Self-reported Physical Activity With Laboratory Markers of Nutrition and Inflammation: The Comprehensive Dialysis Study  Shuchi Anand,
C-reactive protein and dialysis access
Piyawan Kittiskulnam, MD, Glenn M. Chertow, MD, MPH, George A
Volume 72, Issue 5, Pages (September 2007)
Reassessment of the care of the patient with chronic kidney disease
C-reactive protein and dialysis access
Volume 75, Issue 11, Pages (June 2009)
Mortality caused by sepsis in patients with end-stage renal disease compared with the general population  Mark J. Sarnak, Bertrand L. Jaber  Kidney International 
Susumu Takahashi, Kazuyoshi Okada, Mitsuru Yanai  Kidney International 
Volume 54, Issue 2, Pages (August 1998)
Manjula Kurella, Jennifer Luan, Kristine Yaffe, Glenn M. Chertow 
Yasuhiro Hamada, Masafumi Fukagawa  Kidney International 
Kamyar Kalantar-Zadeh  Kidney International 
Jeffrey C. Fink, Glenn M. Chertow  Kidney International 
The progression of chronic kidney disease: A 10-year population-based study of the effects of gender and age  B.O. Eriksen, O.C. Ingebretsen  Kidney International 
George A. Kaysen, Burl R. Don
Albuminuria as a predictor of cardiovascular and renal outcomes in people with known atherosclerotic cardiovascular disease  Johannes F.E. Mann, Qi-Long.
Volume 68, Issue 6, Pages (December 2005)
C.Y. Hsu, J.D. Ordoñez, G.M. Chertow, D. Fan, C.E. McCulloch, A.S. Go 
Volume 56, Issue 2, Pages (August 1999)
How to interpret the eGFR in patients with small body surface area
The importance of increased dialysis and anemia management for infant survival in pregnant women on hemodialysis  Sai Subhodhini Reddy, Jean L. Holley 
Volume 57, Issue 6, Pages (June 2000)
Volume 77, Issue 7, Pages (April 2010)
Renal risk scores: Progress and prospects
Volume 77, Issue 2, Pages (January 2010)
Nephrology Crosswords: Hemodialysis
Bradley A. Ford, Daniel W. Coyne, Charles S. Eby, Mitchell G. Scott 
U-shaped effect of eGFR and mortality
Acute myocardial infarction in patients with end-stage renal disease
Volume 70, Issue 12, Pages (December 2006)
Smaller left kidney in low birth weight children
Volume 65, Issue 6, Pages (June 2004)
Volume 78, Issue 2, Pages (July 2010)
Yijian Huang, Rebecca Zhang, Steven D. Culler, Nancy G. Kutner 
Cynthia Delgado, MD, Patricia Ward, RD, MPH, Glenn M
Volume 66, Issue 2, Pages (August 2004)
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Alternate-day dialysis may be needed for hemodialysis patients
Nephrology Crossword: Peritoneal Dialysis
Trends and Outcomes Associated With Serum Albumin Concentration Among Incident Dialysis Patients in the United States  George A. Kaysen, MD, PhD, Kirsten.
Cardiovascular disease in pediatric chronic dialysis patients
Volume 76, Issue 8, Pages (October 2009)
Nephrology Crossword: Glomerulonephritis
Volume 76, Issue 8, Pages (October 2009)
Volume 81, Issue 9, Pages (May 2012)
Racial differences in survival of patients on dialysis
Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants  C.A. Solid,
Volume 65, Issue 6, Pages (June 2004)
Long-term outcome of dialysis patients in the United States with coronary revascularization procedures  Charles A. Herzog, M.D., Jennie Z. Ma, Allan J.
Volume 60, Issue 6, Pages (December 2001)
Volume 74, Issue 7, Pages (October 2008)
Charles A. Herzog  Kidney International 
Assessing the impact of different imputation methods on serial measures of renal function: The Strong Heart Study  N.-M. Shara, J.-G. Umans, W. Wang,
ANCA comes of age—but with caveats
Volume 87, Issue 3, Pages (March 2015)
Changes to the End-Stage Renal Disease Quality Incentive Program
Volume 82, Issue 9, Pages (November 2012)
The International Pediatric Peritonitis Registry: Starting to walk
A nationwide cohort study suggests chronic hepatitis B virus infection increases the risk of end-stage renal disease among patients in Taiwan  Yi-Chun.
Mary B. Leonard, Lynn A. Donaldson, Martin Ho, Denis F. Geary 
Volume 63, Issue 3, Pages (March 2003)
Presentation transcript:

Volume 78, Issue 11, Pages 1164-1170 (December 2010) Low level of self-reported physical activity in ambulatory patients new to dialysis  Kirsten L. Johansen, Glenn M. Chertow, Nancy G. Kutner, Lorien S. Dalrymple, Barbara A. Grimes, George A. Kaysen  Kidney International  Volume 78, Issue 11, Pages 1164-1170 (December 2010) DOI: 10.1038/ki.2010.312 Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 1 Human Activity Profile (HAP) scores among men and women in the Comprehensive Dialysis Study (CDS) compared with norms for healthy individuals. The black boxes represent the 25th to 50th percentile; gray boxes represent the 50th to 75th percentile; lines above and below extend to the 99th and 1st percentile, respectively. In each figure, scores are shown by age group, beginning with age <40 and progressing by decade to age 70+ years. Within each age group, normative data are represented on the left and CDS participants’ data are plotted on the right. (a, b) Maximum Activity Scores (MAS) and (c, d) Adjusted Activity Scores (AAS) for men and women are shown. Kidney International 2010 78, 1164-1170DOI: (10.1038/ki.2010.312) Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 2 Unadjusted and adjusted Human Activity Profile (HAP) scores according to quartiles of hemoglobin and erythropoietin use. (a) In HAP scores according to quartiles of hemoglobin, the black bars represent the first quartile of hemoglobin (≤8.9 g/dl), diagonally striped bars the second quartile (9.0–10.1 g/dl), horizontally striped bars the third quartile (10.2–11.2 g/dl), gray bars the fourth quartile (≥11.2 g/dl), and white bars those with missing hemoglobin values. (b) In HAP scores based on erythropoietin use, the black bars represent those who did not receive erythropoietin before starting dialysis, gray bars represent those receiving erythropoietin, and white bars those whose receipt of erythropoietin was unknown. AAS, Adjusted Activity Score; MAS, Maximum Activity Score. Kidney International 2010 78, 1164-1170DOI: (10.1038/ki.2010.312) Copyright © 2010 International Society of Nephrology Terms and Conditions